Skip to content

Physical activity and body composition in patients with Ankylosing Spondylitis

Physical activity and body composition in patients with Ankylosing Spondylitis - Body composition in Ankylosing Spondylitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30954
Enrollment
60
Registered
2007-08-02
Start date
2008-03-11
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients, between the age of 18 and 65, diagnosed with Ankylosing Spondylitis (AS) according to the New York Criteria for AS, with a BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) >4, eligible for anti-TNF therapy according to the national guidelines. Healthy controls: same gender, age within 5 years (and between 18 and 65) and family member of the respective patient.

Exclusion criteria

Exclusion criteria: Patients with other conditions known to affect energy metabolism (energy intake and/or expenditure) such as chronic inflammatory disorders (inflammatory bowel disease, COPD, rheumatoid arthritis,..), malignancies, AIDS, dieting will be excluded. Controls will be excluded when any disorder known to affect energy metabolism is present (Ankylosing Spondylitis or any disorder listed above). Subjects that meet any of the exclusion criteria for MRI (electronic implants, pacemakers, metal fragments in the eyes, skin or body) will be excluded.

Design outcomes

Primary

MeasureTime frame
muscle mass (body compostition), physical activity, physical fitness, markers of inflammation and muscle metabolism

Secondary

MeasureTime frame
questionnaire assessed quality of life, disease activity, fatigue

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)